StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
301009.SZ$9.63-1.83%
Fair $9.63+0.0%

301009.SZ

Hangzhou Coco Healthcare Products Co.,Ltd.

Consumer Defensive / Household & Personal ProductsShenzhen

$9.63

-0.18 (-1.83%)

Fairly Valued+0.0%Fair Value $9.63Fund rank 31/100 · Data gapFallback financials|
SA 35/D
F-Score: 7/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 20%

FCF escenarios

weak_data · normalized FCF $86.9M · quality 55.3/100

Data gap 31/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 28/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

35/100

D

Piotroski

7/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is 2.7%, below the 5% threshold
Thesis & Journal · 301009.SZLocal privado en este navegador · Hangzhou Coco Healthcare Products Co.,Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$2.6B

P/E

120.4x

↑

EV/EBITDA

18.1x

↑

ROE

2.7%

↓

Gross Margin

24.0%

↓

Debt/Equity

0.16

↓
52-Week Range$10
$9$19

TradingView lightweight chart

301009.SZ price, volumen y niveles de valoración

Último $9.630Periodo -62.7%
Fair value: $9.630

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-1.0%

FCF CAGR

—

FCF margin

7.6%

FCF / Net income

2.41x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.15B · net income $36.1M · FCF $86.9M

2022-FY → 2025-FY

Gross margin

24.0%+10.9% pts

Operating margin

3.1%+4.4% pts

Net margin

3.1%+6.8% pts

FCF margin

7.6%+20.5% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$1.15B$1.15B$1.08B$1.08B$1.19B
Net Income$36.1M$36.1M$31.2M$20.2M$-43.1M
EBITDA$103.8M$103.8M$92.2M$76.9M$5.2M
EPS0.140.140.120.07-0.16
Gross Margin24.0%24.0%20.8%17.7%13.1%
Operating Margin3.1%3.1%1.8%1.5%-1.3%
Net Margin3.1%3.1%2.9%1.9%-3.6%
Balance Sheet
Debt/Equity0.160.160.080.010.00
Current Ratio1.991.99———
Cash Flow
Free Cash Flow$86.9M$86.9M$-22.9M$161.7M$-153.6M
Returns
ROE2.7%2.7%2.3%1.5%-3.2%
Valuation
P/E120.38120.3883.83152.57—
EV/EBITDA18.1418.1422.9029.04525.95
P/B1.851.851.962.242.51
Growth & Yield
Revenue Growth6.6%6.6%-0.3%-8.8%—
EPS Growth16.7%16.7%71.4%143.8%—
Dividend Yield0.7%0.7%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

82.8%

muy exigente

EPS terminal req.

$0.85

Spread vs growth

-66.1%

5Y implied EPS CAGR

49.2%

muy exigente

EPS terminal req.

$1.03

Spread vs growth

-32.5%

10Y implied EPS CAGR

28.1%

muy exigente

EPS terminal req.

$1.67

Spread vs growth

-11.4%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -35.3%

Total return

-35.3%

Start / end P/E

125.5x → 68.8x

EPS bridge

0.12 → 0.14

Residual

-7.5%

EPS growth+16.7%
Multiple rerating-45.2%
Dividend+0.7%
Residual / FX / buybacks / cross-term-7.5%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.